查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1949189

全球放射肿瘤市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Radiation Oncology Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 141 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计放射肿瘤学市场将从 2025 年的 102.7 亿美元成长到 2034 年的 192.5 亿美元，2026 年至 2034 年的复合年增长率为 7.23%。

受癌症发病率上升和对有效治疗方法需求不断增长的推动，放射肿瘤市场预计将显着增长。随着全球癌症发生率持续攀升，对先进放射治疗解决方案的需求日益迫切。放射肿瘤学涵盖多种技术，包括体外放射治疗、近距离放射放射治疗和立体定位放射线手术，所有这些技术对于综合治疗各种类型的癌症都至关重要。强度调控放射治疗(IMRT) 和影像导航放射治疗(IGRT) 等先进技术的整合正在提高治疗的精确性和有效性，从而改善患者预后并最大限度地减少副作用。

此外，放射肿瘤学技术的进步正在推动市场创新。质子疗法和其他粒子束疗法的发展正在革新癌症治疗，它们能够提供标靶放射治疗，有效治疗肿瘤的同时保护健康组织。这些先进治疗方法对儿童患者以及肿瘤位于重要结构附近的患者尤其有益。随着放射肿瘤学领域新应用和新技术的不断探索，预计随着治疗效果和患者安全性的提高，市场将进一步扩张。

此外，对个人化医疗的日益重视正在重塑放射肿瘤学的格局。随着医疗服务提供者基于基因和分子谱分析为每位患者量身定制治疗方案，对符合个人化治疗计划的放射线治疗的需求预计将会增加。这一趋势在联合治疗领域尤其重要，联合治疗是指将放射线治疗与免疫疗法或标靶治疗合併使用，以提高治疗效果。随着放射肿瘤学市场的不断发展，技术创新、个人化治疗方法以及对改善患者预后的关注将在其未来发展轨迹中发挥关键作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球放射肿瘤市场：依产品类型划分

  • 市场分析、洞察与预测
  • 体外放射线治疗
  • 内放射线治疗
  • 全身放射线治疗

第五章：全球放射肿瘤市场：依应用划分

  • 市场分析、洞察与预测
  • 乳癌
  • 肺癌
  • 摄护腺癌
  • 结肠癌
  • 头颈癌
  • 其他的

第六章 全球放射肿瘤市场：依最终用户划分

  • 市场分析、洞察与预测
  • 医院
  • 门诊放射治疗中心
  • 癌症研究机构
  • 其他的

第七章 全球放射肿瘤市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Siemens Healthineers
    • GE Healthcare
    • Philips Healthcare
    • Varian Medical Systems
    • Elekta
    • Hitachi Medical Corporation
    • IBA Worldwide
    • Accuray Incorporated
    • Advanced Accelerator Applications
    • Nordion Inc
简介目录
Product Code: VMR11219481

The Radiation Oncology Market size is expected to reach USD 19.25 Billion in 2034 from USD 10.27 Billion (2025) growing at a CAGR of 7.23% during 2026-2034.

The radiation oncology market is poised for significant growth, driven by the increasing incidence of cancer and the rising demand for effective treatment modalities. As cancer rates continue to escalate globally, the need for advanced radiation therapy solutions is becoming more critical. Radiation oncology encompasses a range of techniques, including external beam radiation therapy, brachytherapy, and stereotactic radiosurgery, all of which are essential in the comprehensive management of various cancer types. The integration of cutting-edge technologies, such as intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), is enhancing the precision and effectiveness of treatment, thereby improving patient outcomes and minimizing side effects.

Moreover, advancements in radiation oncology technologies are driving innovation within the market. The development of proton therapy and other particle therapies is revolutionizing cancer treatment by providing targeted radiation that spares healthy tissues while effectively treating tumors. These advanced modalities are particularly beneficial for pediatric patients and those with tumors located near critical structures. As research continues to explore new applications and techniques in radiation oncology, the market is likely to expand further, fueled by the promise of improved therapeutic efficacy and patient safety.

Additionally, the growing emphasis on personalized medicine is shaping the radiation oncology landscape. As healthcare providers increasingly seek to tailor treatments to individual patients based on genetic and molecular profiling, the demand for radiation therapy that aligns with personalized treatment plans is expected to rise. This trend is particularly relevant in the context of combination therapies, where radiation is used alongside immunotherapy or targeted therapies to enhance treatment effectiveness. As the radiation oncology market continues to evolve, the convergence of technological advancements, personalized treatment approaches, and a focus on improving patient outcomes will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • External Beam Radiation Therapy
  • Internal Beam Radiation Therapy
  • Systemic Radiation Therapy

By Application

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Head and Neck Cancer
  • Others

By End-User

  • Hospitals
  • Ambulatory Radiotherapy Centers
  • Cancer Research Institutes
  • Others

COMPANIES PROFILED

  • Siemens Healthineers, GE Healthcare, Philips Healthcare, Varian Medical Systems, Elekta, Hitachi Medical Corporation, IBA Worldwide, Accuray Incorporated, Advanced Accelerator Applications, Nordion Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL RADIATION ONCOLOGY MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. External Beam Radiation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Internal Beam Radiation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Systemic Radiation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RADIATION ONCOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Colorectal Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Head and Neck Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RADIATION ONCOLOGY MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Radiotherapy Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Cancer Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL RADIATION ONCOLOGY MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product Type
    • 7.2.2 By Application
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product Type
    • 7.3.2 By Application
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product Type
    • 7.4.2 By Application
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product Type
    • 7.5.2 By Application
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product Type
    • 7.6.2 By Application
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL RADIATION ONCOLOGY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Siemens Healthineers
    • 9.2.2 GE Healthcare
    • 9.2.3 Philips Healthcare
    • 9.2.4 Varian Medical Systems
    • 9.2.5 Elekta
    • 9.2.6 Hitachi Medical Corporation
    • 9.2.7 IBA Worldwide
    • 9.2.8 Accuray Incorporated
    • 9.2.9 Advanced Accelerator Applications
    • 9.2.10 Nordion Inc